Analytical Data
-
Gene name
C11orf70
- Application
-
Alternative Names
CFAP300; C11orf70Cilia- and flagella-associated Protein 300
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BRQ4
-
Expression Region
1-267aa
-
AA Sequence
MATGELGDLG GYYFRFLPQK TFQSLSSKEI TSRLRQWSML GRIKAQAFGF DQTFQSYRKD DFVMAFFKDP NVIPNLKLLS DSSGQWIILG TEVKKIEAIN VPCTQLSMSF FHRLYDEDIV RDSGHIVKCL DSFCDPFLIS DELRRVLLVE DSEKYEIFSQ PDREEFLFCL FKHLCLGGAL CQYEDVISPY LETTKLIYKD LVSVRKNPQT KKIQITSSVF KVSAYDSAGM CYPSAKNHEQ TFSYFIVDPI RRHLHVLYHC YGVGDMS
-
Molecular Weight
30.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C11orf70, a gene located on chromosome 11, has recently garnered attention in the field of molecular biology due to its potential roles in various physiological and pathological processes. Initial studies have suggested that C11orf70 may be involved in cellular functions, although its specific biological role remains largely uncharacterized. Recent research has indicated that C11orf70 might play a critical part in neurodevelopmental and neurological disorders, making it a candidate for further exploration in these contexts. Given its significant expression in certain tissues, particularly the brain, interest has grown in understanding its functional properties through the development of recombinant proteins. This approach enables researchers to investigate the biochemical properties, potential interactions, and mechanisms of action of C11orf70 in a controlled environment. Furthermore, recombinant protein studies can facilitate the identification of downstream signaling pathways and biological networks associated with this gene, which could ultimately lead to new therapeutic targets for diseases linked to its dysfunction. As the field advances, continued research on C11orf70 and its recombinant protein will be crucial for deciphering its role in health and disease, helping to bridge the gaps in our understanding of its contribution to human biology.
